Psoriasis, psoriatic arthritis and risk of gout in US men and women

Annals of the Rheumatic Diseases

Volumn 74, Issue 8, 2015, Pages 1495-1500

  Merola, Joseph F ^a   Wu, Shaowei ^a   Han, Jiali ^a,b,c,d   Choi, Hyon K ^b,e   Qureshi, Abrar A ^a,b,f  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GOUT; HIGH RISK POPULATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIASIS; PSORIATIC ARTHRITIS; QUESTIONNAIRE; RISK FACTOR; UNITED STATES; AGED; ARTHRITIS, PSORIATIC; BLOOD; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT;

URIC ACID;

ADULT; AGED; ARTHRITIS, PSORIATIC; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PSORIASIS; RISK ASSESSMENT; RISK FACTORS; UNITED STATES; URIC ACID;

EID: 84940370273     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2014-205212     Document Type: Article

References (49)

1. Gelfand JM, Gladman DD, Mease PJ, et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 2005;53:573.
2. Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum 2009;61:1373-8.
3. Prey S, Paul C, Bronsard V, et al. Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: a systematic review of the literature. J Eur Acad Dermatol Venereol 2010;24(Suppl 2):31-5.
4. Ten Klooster PM, Vonkeman HE, Oude Voshaar MA, et al. Experiences of gout-related disability from the patients' perspective: a mixed methods study. Clin Rheumatol 2013. Epub 2013/10/01.
5. Velez NF, Wei-Passanese EX, Husni ME, et al. Management of psoriasis and psoriatic arthritis in a combined dermatology and rheumatology clinic. Arch Dermatol Res 2012;304:7-13.
6. Mody E, Husni ME, Schur P, et al. Multidisciplinary evaluation of patients with psoriasis presenting with musculoskeletal pain: a dermatology: rheumatology clinic experience. Br J Dermatol 2007;157:1050-1.
7. Kwon HH, Kwon IH, Choi JW, et al. Cross-sectional study on the correlation of serum uric acid with disease severity in Korean patients with psoriasis. Clin Exp Dermatol 2011;36:473-8.
8. Isha, Jain VK, Lal H. C-reactive protein and uric acid levels in patients with psoriasis. Indian J Clin Biochem 2011;26:309-11.
9. Choi HK, Atkinson K, Karlson EW, et al. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004;350:1093-103.
10. Bruce IN, Schentag CT, Gladman DD. Hyperuricemia in psoriatic arthritis: prevalence and associated features. J Clin Rheumatol 2000;6:6-9.
11. Goldman M. Uric acid in the etiology of psoriasis. Am J Dermatopathol 1981;3:397-404.
12. Kanellis J, Watanabe S, Li JH, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-Activated protein kinase and cyclooxygenase-2. Hypertension 2003;41:1287-93.
13. Inaba S, Sautin Y, Garcia GE, et al. What can asymptomatic hyperuricaemia and systemic inflammation in the absence of gout tell us Rheumatology 2013;52:963-5.
14. Bosmansky K, Trnavsky K. Psoriasis and gout: report of 4 cases. Clin Rheumatol 1983;2:423-6.
15. Cho S, Koh GJ, Choi JH, et al. Chronic tophaceous gout presenting as hyperpigmented nodules in the limbs of a patient with coexisting psoriasis. J Dermatol 2001;28:433-6.
16. Liu M, Li JH, Li B, et al. Coexisting gout, erythrodermic psoriasis and psoriatic arthritis. Eur J Dermatol 2009;19:184-5.
17. Lopez-Reyes A, Hernandez-Diaz C, Hofmann F, et al. Gout mimicking psoriatic arthritis flare. J Clin Rheumatol 2012;18:220.
18. Dominguez PL, Assarpour A, Kuo H, et al. Development and pilot-testing of a psoriasis screening tool. Br J Dermatol 2009;161:778-84.
19. Husni ME, Meyer KH, Cohen DS, et al. The PASE questionnaire: pilot-testing a psoriatic arthritis screening and evaluation tool. J Am Acad Dermatol 2007;57:581-7.
20. Wu S, WQ Li, J Han, et al. Hypercholesterolemia and risk of incident psoriasis and psoriatic arthritis in US women. Arthritis Rheum (in press).
21. Dominguez PL, Husni ME, Holt EW, et al. Validity, reliability, and sensitivity-to-change properties of the psoriatic arthritis screening and evaluation questionnaire. Arch Dermatol Res 2009;301:573-9.
22. Choi HK, Curhan G. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ 2008;336:309-12.
23. Choi HK, Atkinson K, Karlson EW, et al. Alcohol intake and risk of incident gout in men: a prospective study. Lancet 2004;363:1277-81.
24. Choi HK, Willett W, Curhan G. Fructose-rich beverages and risk of gout in women. JAMA 2010;304:2270-8.
25. Wallace SL, Robinson H, Masi AT, et al. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977;20:895-900.
26. Choi HK. A prescription for lifestyle change in patients with hyperuricemia and gout. Curr Opin Rheumatol 2010;22:165-72.
27. Kienhorst LB, Janssens HJ, Fransen J, et al. Arthritis of the first metatarsophalangeal joint is not always gout: A prospective cohort study in primary care patients. Joint Bone Spine 2014. Epub 2014/01/29.
28. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985;122:51-65.
29. Mozaffarian D, Hao T, Rimm EB, et al. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med 2011;364:2392-404.
30. Willett WC. Nutritional epidemiology. 2nd edn. New York: Oxford University Press, 1998.
31. Smith-Warner SA, Spiegelman D, Ritz J, et al. Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol 2006;163:1053-64.
32. Singh JA. Racial and gender disparities among patients with gout. Curr Rheumatol Reports 2013;15:307.
33. Arromdee E, Michet CJ, Crowson CS, et al. Epidemiology of gout: is the incidence rising J Rheumatol 2002;29:2403-6.
34. Hall AP, Barry PE, Dawber TR, et al. Epidemiology of gout and hyperuricemia. A long-term population study. Am J Med 1967;42:27-37.
35. Currie WJ. Prevalence and incidence of the diagnosis of gout in Great Britain. Ann Rheum Dis 1979;38:101-6.
36. Harris CM, Lloyd DC, Lewis J. The prevalence and prophylaxis of gout in England. J Clin Epidemiol 1995;48:1153-8.
37. Gonzalez-Gay MA, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Role of asymptomatic hyperuricemia and serum uric acid levels in the pathogenesis of subclinical atherosclerosis in psoriatic arthritis: comment on the article by Chen et al. Arthritis Rheum 2009;61:856-7; author reply 7-8.
38. Gonzalez-Gay MA, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, et al. Asymptomatic hyperuricemia and serum uric acid concentration correlate with subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease. Semin Arthritis Rheum 2009;39:157-62.
39. Gisondi P, Targher G, Cagalli A, et al. Hyperuricemia in patients with chronic plaque psoriasis. J Am Acad Dermatol 2014;70:127-30.
40. Oliviero F, Scanu A, Galozzi P, et al. Prevalence of calcium pyrophosphate and monosodium urate crystals in synovial fluid of patients with previously diagnosed joint diseases. Joint Bone Spine 2013;80:287-90.
41. Kanellis J, Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Sem Nephrol 2005;25:39-42.
42. Prasad PV, Bikku B, Kaviarasan PK, et al. A clinical study of psoriatic arthropathy. Indian J Dermatol Venereol Leprol 2007;73:166-70.
43. Rock KL, Kataoka H, Lai JJ. Uric acid as a danger signal in gout and its comorbidities. Nat Rev Rheumatol 2013;9:13-23.
44. Horreau C, Pouplard C, Brenaut E, et al. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol 2013;27(Suppl 3):12-29.
45. Lin YC, Dalal D, Churton S, et al. Relationship between metabolic syndrome and carotid intima media thickness: Cross-sectional comparison between psoriasis and psoriatic arthritis. Arthritis Care Res 2014;66:97-103.
46. Onat A, Can G, Ornek E, et al. Elevated serum uric acid in nondiabetic people mark pro-inflammatory state and HDL dysfunction and independently predicts coronary disease. Clin Rheumatol 2013;32:1767-75.
47. Richette P, Perez-Ruiz F. Serum uric acid and metabolic risk. Curr Med Res Opin 2013;29(Suppl 3):9-15.
48. Cassano N, Carbonara M, Panaro M, et al. Role of serum uric acid in conditioning the association of psoriasis with metabolic syndrome. Eur J Dermatol 2011;21:808-9.
49. Haroon M, Kirby B, FitzGerald O. High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires. Ann Rheum Dis 2013;72:736-40.